Drug development (and academic medicine)

charting the course forward

Research output: Contribution to journalEditorial

2 Citations (Scopus)

Abstract

Drug development is both scientifically and economically driven. Past efforts to support the process have had great success, but increasing economic and regulatory pressures again threaten continued progress. The path from discovery to clinical use is in need of reevaluation with regard to substantive changes to reenergize the process. Such reevaluation includes clinical pharmacology input from all in our academia, industry, and regulatory sectors.

Original languageEnglish (US)
Pages (from-to)519-522
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume96
Issue number5
DOIs
StatePublished - Nov 1 2014

Fingerprint

Clinical Pharmacology
Industry
Economics
Medicine
Pressure
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{2c98697faa734a56b923b678651cfa15,
title = "Drug development (and academic medicine): charting the course forward",
abstract = "Drug development is both scientifically and economically driven. Past efforts to support the process have had great success, but increasing economic and regulatory pressures again threaten continued progress. The path from discovery to clinical use is in need of reevaluation with regard to substantive changes to reenergize the process. Such reevaluation includes clinical pharmacology input from all in our academia, industry, and regulatory sectors.",
author = "Raymond Hohl",
year = "2014",
month = "11",
day = "1",
doi = "10.1038/clpt.2014.171",
language = "English (US)",
volume = "96",
pages = "519--522",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "5",

}

Drug development (and academic medicine) : charting the course forward. / Hohl, Raymond.

In: Clinical Pharmacology and Therapeutics, Vol. 96, No. 5, 01.11.2014, p. 519-522.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Drug development (and academic medicine)

T2 - charting the course forward

AU - Hohl, Raymond

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Drug development is both scientifically and economically driven. Past efforts to support the process have had great success, but increasing economic and regulatory pressures again threaten continued progress. The path from discovery to clinical use is in need of reevaluation with regard to substantive changes to reenergize the process. Such reevaluation includes clinical pharmacology input from all in our academia, industry, and regulatory sectors.

AB - Drug development is both scientifically and economically driven. Past efforts to support the process have had great success, but increasing economic and regulatory pressures again threaten continued progress. The path from discovery to clinical use is in need of reevaluation with regard to substantive changes to reenergize the process. Such reevaluation includes clinical pharmacology input from all in our academia, industry, and regulatory sectors.

UR - http://www.scopus.com/inward/record.url?scp=84924928672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924928672&partnerID=8YFLogxK

U2 - 10.1038/clpt.2014.171

DO - 10.1038/clpt.2014.171

M3 - Editorial

VL - 96

SP - 519

EP - 522

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 5

ER -